343 related articles for article (PubMed ID: 32249615)
21. Requirement of Toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis.
Savarese E; Steinberg C; Pawar RD; Reindl W; Akira S; Anders HJ; Krug A
Arthritis Rheum; 2008 Apr; 58(4):1107-15. PubMed ID: 18383384
[TBL] [Abstract][Full Text] [Related]
22. BTK inhibition ameliorates kidney disease in spontaneous lupus nephritis.
Chalmers SA; Glynn E; Garcia SJ; Panzenbeck M; Pelletier J; Dimock J; Seccareccia E; Bosanac T; Khalil S; Harcken C; Webb D; Nabozny G; Fine JS; Souza D; Klein E; Herlitz L; Ramanujam M; Putterman C
Clin Immunol; 2018 Dec; 197():205-218. PubMed ID: 30339790
[TBL] [Abstract][Full Text] [Related]
23. Mangiferin Attenuates Murine Lupus Nephritis by Inducing CD4+Foxp3+ Regulatory T Cells via Suppression of mTOR Signaling.
Liang CL; Lu W; Zhou JY; Chen Y; Zhang Q; Liu H; Qiu F; Dai Z
Cell Physiol Biochem; 2018; 50(4):1560-1573. PubMed ID: 30359968
[TBL] [Abstract][Full Text] [Related]
24. Abrogation of pathogenic IgG autoantibody production in CD40L gene-deleted lupus-prone New Zealand Black mice.
Pau E; Chang NH; Loh C; Lajoie G; Wither JE
Clin Immunol; 2011 May; 139(2):215-27. PubMed ID: 21414847
[TBL] [Abstract][Full Text] [Related]
25. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
Lichtnekert J; Rupanagudi KV; Kulkarni OP; Darisipudi MN; Allam R; Anders HJ
J Immunol; 2011 Sep; 187(6):3413-21. PubMed ID: 21849682
[TBL] [Abstract][Full Text] [Related]
26. Preclinical Testing of Viral Therapeutic Efficacy in Pristane-Induced Lupus Nephritis and Diffuse Alveolar Hemorrhage Mouse Models.
Guo Q; Zhang L; Yaron JR; Burgin M; Schutz LN; Awo EA; Lucas AR
Methods Mol Biol; 2021; 2225():241-255. PubMed ID: 33108667
[TBL] [Abstract][Full Text] [Related]
27. Pim-1 as a Therapeutic Target in Lupus Nephritis.
Fu R; Xia Y; Li M; Mao R; Guo C; Zhou M; Tan H; Liu M; Wang S; Yang N; Zhao J
Arthritis Rheumatol; 2019 Aug; 71(8):1308-1318. PubMed ID: 30791224
[TBL] [Abstract][Full Text] [Related]
28. Oral supplementation of melatonin protects against lupus nephritis renal injury in a pristane-induced lupus mouse model.
Dos Santos M; Favero G; Bonomini F; Stacchiotti A; Rodella LF; Veronese FV; Rezzani R
Life Sci; 2018 Jan; 193():242-251. PubMed ID: 29097157
[TBL] [Abstract][Full Text] [Related]
29. Vasoactive intestinal peptide ameliorates renal injury in a pristane-induced lupus mouse model by modulating Th17/Treg balance.
Fu D; Senouthai S; Wang J; You Y
BMC Nephrol; 2019 Sep; 20(1):350. PubMed ID: 31488076
[TBL] [Abstract][Full Text] [Related]
30. Disparate T cell requirements of two subsets of lupus-specific autoantibodies in pristane-treated mice.
Richards HB; Satoh M; Jennette JC; Okano T; Kanwar YS; Reeves WH
Clin Exp Immunol; 1999 Mar; 115(3):547-53. PubMed ID: 10193432
[TBL] [Abstract][Full Text] [Related]
31. Resveratrol possesses protective effects in a pristane-induced lupus mouse model.
Wang ZL; Luo XF; Li MT; Xu D; Zhou S; Chen HZ; Gao N; Chen Z; Zhang LL; Zeng XF
PLoS One; 2014; 9(12):e114792. PubMed ID: 25501752
[TBL] [Abstract][Full Text] [Related]
32. Induction of systemic lupus erythematosus syndrome in BALB/c mice by immunization with active chromatin.
Li H; Zhang YY; Sun YN; Huang XY; Jia YF; Li D
Acta Pharmacol Sin; 2004 Jun; 25(6):807-11. PubMed ID: 15169636
[TBL] [Abstract][Full Text] [Related]
33. Complement 1q protects MRL/lpr mice against lupus nephritis via inhibiting the nuclear factor-κB pathway.
Sun J; Guo S; Niu F; Liu D; Zhuang Y
Mol Med Rep; 2020 Dec; 22(6):5436-5443. PubMed ID: 33173997
[TBL] [Abstract][Full Text] [Related]
34. α-mangostin attenuates pristane-induced lupus nephritis by regulating Th17 differentiation.
Zhou X; Chen H; Wei F; Zhao Q; Su Q; Lei Y; Yin M; Tian X; Liu Z; Yu B; Bai C; He X; Huang Z
Int J Rheum Dis; 2020 Jan; 23(1):74-83. PubMed ID: 31769201
[TBL] [Abstract][Full Text] [Related]
35. Retinoic Acid Exerts Disease Stage-Dependent Effects on Pristane-Induced Lupus.
Abdelhamid L; Cabana-Puig X; Swartwout B; Lee J; Li S; Sun S; Li Y; Ross AC; Cecere TE; LeRoith T; Werre SR; Wang H; Reilly CM; Luo XM
Front Immunol; 2020; 11():408. PubMed ID: 32265909
[TBL] [Abstract][Full Text] [Related]
36. B Cell Abnormalities in Systemic Lupus Erythematosus and Lupus Nephritis-Role in Pathogenesis and Effect of Immunosuppressive Treatments.
Yap DYH; Chan TM
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835612
[TBL] [Abstract][Full Text] [Related]
37. Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis.
Lee HT; Shiao YM; Wu TH; Chen WS; Hsu YH; Tsai SF; Tsai CY
J Rheumatol; 2010 Jan; 37(1):45-52. PubMed ID: 19955043
[TBL] [Abstract][Full Text] [Related]
38. Vitamin D supplementation ameliorates arthritis but does not alleviates renal injury in pristane-induced lupus model.
Correa Freitas E; Evelyn Karnopp T; de Souza Silva JM; Cavalheiro do Espírito Santo R; da Rosa TH; de Oliveira MS; da Costa Gonçalves F; de Oliveira FH; Guilherme Schaefer P; André Monticielo O
Autoimmunity; 2019 Mar; 52(2):69-77. PubMed ID: 31088305
[TBL] [Abstract][Full Text] [Related]
39. Upregulation of FcγRIIB by resveratrol via NF-κB activation reduces B-cell numbers and ameliorates lupus.
Jhou JP; Chen SJ; Huang HY; Lin WW; Huang DY; Tzeng SJ
Exp Mol Med; 2017 Sep; 49(9):e381. PubMed ID: 28960214
[TBL] [Abstract][Full Text] [Related]
40. Btk-specific inhibition blocks pathogenic plasma cell signatures and myeloid cell-associated damage in IFN
Katewa A; Wang Y; Hackney JA; Huang T; Suto E; Ramamoorthi N; Austin CD; Bremer M; Chen JZ; Crawford JJ; Currie KS; Blomgren P; DeVoss J; DiPaolo JA; Hau J; Johnson A; Lesch J; DeForge LE; Lin Z; Liimatta M; Lubach JW; McVay S; Modrusan Z; Nguyen A; Poon C; Wang J; Liu L; Lee WP; Wong H; Young WB; Townsend MJ; Reif K
JCI Insight; 2017 Apr; 2(7):e90111. PubMed ID: 28405610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
